Favorable long-term toxicity for salvage low-dose rate prostate brachytherapy for recurrent prostate cancer after external beam radiotherapy from a phase II prospective trial (NRG Oncology/RTOG 0526)

Affiliations

• ¹ Department of Radiation Oncology, Washington University in St. Louis, St. Louis, MO, USA.
• ² Princeton Radiation Oncology, Princeton, NJ, USA.
• ³ Department of Radiation Oncology, Dana-Farber Cancer Institute, and Brigham and Women's Hospital, Boston, MA, USA.
• ⁴ Harvard Medical School, Boston, MA, USA.
• ⁵ Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
• ⁶ Leonard Davis Institute of Healthcare Economics, University of Pennsylvania, Philadelphia, PA, USA.